Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 30, 2015 8:57 AM ET


Company Overview of Liventa Bioscience

Company Overview

AFCell Medical, Inc. produces and supplies amniotic membrane-based biomaterial technology solutions. The company offers amnion, as well as other birth tissue products, such as chorion and amniotic fluids. It also provides AmnioClear, a human allograft membrane transplant for surgical use and to be placed over damaged internal membranes. The company was formerly known as PearlDiver Technologies, Inc. and changed its name to AFCell Medical, Inc. in September 2011. AFCell Medical, Inc. was founded in 2006 and is based in Parsippany, New Jersey.

322 Route 46W

Suite 150

Parsippany, NJ 07054

United States

Founded in 2006





Key Executives for Liventa Bioscience

Founder and Chief Executive Officer
Chief Operating Officer
Age: 53
Compensation as of Fiscal Year 2015.

Liventa Bioscience Key Developments

The Musculoskeletal Transplant Foundation Reconfirms Favorable Ruling from the Patent Trial and Appeal Board

The Musculoskeletal Transplant Foundation (MTF) reconfirmed on September 1, 2015 that the Patent Trial and Appeal Board of the United States Patent and Trademark Office has ruled in favor of MTF's inter partes review challenge to the EpiFix patent (U.S. Patent No. 8,372,437) asserted in the related lawsuit brought by MiMedx Group, Inc. against MTF, Liventa Bioscience, Inc., and Medline Industries, Inc. The '437 Patent is the initial patent in a family that includes two other EpiFix patents involved in the MiMedx lawsuit (US Patent Nos. 8,597,687 and 8,709,494).

MiMedx Group, Inc. Receives Favorable Rulings from Patent Trial and Review Board against Lawsuit of Liventa Bioscience, Inc., Medline Industries, Inc., Musculoskeletal Transplant Foundation, Inc., Transplant Technology, Inc. and Texas Human Biologics Ltd

MiMedx Group, Inc. announced the Patent Trial and Appeal Board has ruled in favor of the company's primary EpiFix and AmnioFix patents. In April 2014, MiMedx filed patent infringement lawsuits in the United States District Court for the Northern District of Georgia against Liventa Bioscience, Inc., Medline Industries, Inc. and Musculoskeletal Transplant Foundation, Inc. for permanent injunctive relief and unspecified damages. In May 2014, the company also filed a separate action against Transplant Technology, Inc. d/b/a Bone Bank Allograft and Texas Human Biologics Ltd. for patent infringement. In both suits, MiMedx asserted that these organizations infringed and continue to infringe at least six MiMedx patents. As part of their defense strategy, two of the four defendants submitted certain of the MiMedx patents to the inter partes review process, which means they are asking the PTAB to review the subject matter covered by the MiMedx patents and decide whether it was proper for the patents to have been granted in the first place. MiMedx received two recent rulings from the PTAB. One PTAB ruling was made in regard the inter partes review request related to the MiMedx primary EpiFix patent and the other recent PTAB decision was for the inter partes review request related to the MiMedx AmnioFix patent. In both rulings, the PTAB found no basis to challenge these patents and fully rejected the request for review on these patents.

Liventa Bioscience Presents at Canaccord Genuity 10th Annual Musculoskeletal Conference, Mar-24-2015 08:30 AM

Liventa Bioscience Presents at Canaccord Genuity 10th Annual Musculoskeletal Conference, Mar-24-2015 08:30 AM. Venue: MGM Grand Hotel, Las Vegas, Nevada, United States.

Similar Private Companies By Industry

Company Name Region
ALS Biopharma, LLC United States
E.I. Spectra, LLC United States
AxioMx, Inc. United States
Abcam, Inc. United States
Analytical Stem Cell Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Liventa Bioscience, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at